# 바이오스페이스 일일 뉴스 리포트 - 2025년 05월 18일


## 주요 헤드라인

1. **BioMarin Expands Enzyme Expertise With $270M Inozyme Buy (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biomarin-expands-enzyme-expertise-with-270m-inozyme-buy>

2. **BioMarin Expands Enzyme Expertise With $270M Inozyme Buy (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/biomarin-expands-enzyme-expertise-with-270m-inozyme-buy>

3. **Sarepta Seeks to Strengthen Elevidys’ Case With Data in Older Kids (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/sarepta-seeks-to-strengthen-elevidys-case-with-data-in-older-kids>

4. **Lilly Makes $1.3B RNA Editing Bet With Rznomics to Build Out Hearing Loss Pipeline (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/lilly-makes-1-3b-rna-editing-bet-with-rznomics-to-build-out-hearing-loss-pipeline>

5. **UPDATED (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/novo-nordisk-ceo-jørgensen-to-depart-with-danish-pharmas-shares-in-freefall>

6. **Radiopharma Powerhouses Push Frontiers With New Indications, Innovation (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/radiopharma-powerhouses-push-frontiers-with-new-indications-innovation>

7. **Radiopharma Powerhouses Push Frontiers With New Indications, Innovation (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/radiopharma-powerhouses-push-frontiers-with-new-indications-innovation>


---
*2025년 05월 18일 바이오스페이스 뉴스 피드에서 생성된 리포트*